+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antiparasitic Drugs Market by Drug Class (Amino-Acetonitrile, Benzimidazoles, Macrocyclic Lactones), Veterinary (Aquaculture, Companion Animals, Livestock) - Global Forecast 2025-2030- Product Image
Antiparasitic Drugs Market by Drug Class (Amino-Acetonitrile, Benzimidazoles, Macrocyclic Lactones), Veterinary (Aquaculture, Companion Animals, Livestock) - Global Forecast 2025-2030- Product Image
Sale

Antiparasitic Drugs Market by Drug Class (Amino-Acetonitrile, Benzimidazoles, Macrocyclic Lactones), Veterinary (Aquaculture, Companion Animals, Livestock) - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715672
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antiparasitic drugs market continues to evolve as animal health imperatives, regulatory shifts, and innovation accelerate across the agriculture and veterinary sectors. Senior decision-makers navigating this complex landscape require in-depth insights to guide investment, strategic alignment, and risk management in a context of global supply chain disruption and increasing resistance threats.

Market Snapshot: Antiparasitic Drugs Market Growth and Trajectory

The Antiparasitic Drugs Market grew from USD 21.12 billion in 2024 to USD 22.18 billion in 2025, and is projected to reach USD 27.95 billion by 2030 at a CAGR of 4.78%. This market trajectory illustrates robust, sustained demand for antiparasitic therapeutics in both established and emerging regions. Increasing regulatory scrutiny, supply chain realignment, and expanded biotechnological advances are key developments directly influencing growth and competitive positioning.

Scope & Segmentation of the Antiparasitic Drugs Market

This comprehensive research assesses the landscape by considering multiple dimensions of the market:

  • Drug Classes: Amino-acetonitriles (e.g., monepantel), benzimidazoles (including albendazole, fenbendazole, mebendazole, oxibendazole, thiabendazole), macrocyclic lactones (abamectin, doramectin, eprinomectin, ivermectin), and spiroindoles (derquantel).
  • Veterinary Applications: Aquaculture (fish, shrimp), companion animals (canine, feline), and livestock (cattle, poultry, swine).
  • Geographical Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and others).
  • Key Industry Players: Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Bayer AG, Ceva Santé Animale S.A., Virbac S.A., Dechra Pharmaceuticals PLC, Vetoquinol S.A., Norbrook Laboratories Limited.
  • Emergent Technologies: Advanced molecular pharmacology, artificial intelligence in drug discovery, genomic platforms, and digital monitoring for resistance trends and distribution optimization.

Key Takeaways for Senior Decision-Makers

  • Innovative compound classes are targeting resistance management, addressing gaps in disease control and broadening the spectrum of parasitic threats managed across animal groups.
  • Collaboration among pharmaceutical companies, biotechnology firms, academic institutions, and contract research organizations is expanding, streamlining pipeline progression and unlocking rapid market adaptation.
  • Distribution is shifting as direct-to-consumer and telemedicine models gain traction, particularly in remote livestock and aquaculture operations, altering traditional supply dynamics.
  • Regulatory frameworks are evolving to prioritize environmental stewardship, novel mechanism validation, and safety across both active ingredients and finished formulations.
  • Strategic portfolio alignment—matching compound classes to specific animal health applications—enables targeted development, enhances stewardship, and sustains product lifecycle value.
  • Regional dynamics influence investment, as markets differ in regulatory complexity, infrastructure maturity, and urgency of disease resistance threats.

Tariff Impact on Antiparasitic Product Supply Chains and Pricing

Recent U.S. tariffs imposed in 2025 have changed the economics of global antiparasitic drug supply chains. Import duties on active pharmaceutical ingredients are generating cost pressures throughout the manufacturing and distribution cycle. To manage these challenges, companies are diversifying raw material sourcing and pursuing local contract manufacturing in low-duty regions. While this shift supports resilience, it also introduces trade-offs in scale efficiency and inventory management, with downstream effects seen in pricing and buyer strategies, including increased consideration of generics and bundled value-added services.

Methodology & Data Sources

This analysis integrates secondary research from regulatory databases, academic journals, and industry filings with primary interviews of subject-matter experts, veterinarians, and supply chain leaders. The research team validated findings through triangulation and industry workshops, while advanced statistical tools were used to contextualize trends and verify market observations.

Why This Antiparasitic Drugs Report Matters

  • Enable informed strategic decisions based on reliable segment, technology, and regional intelligence.
  • Mitigate market entry risk, optimize portfolio strategy, and adapt supply resiliency in a context of ongoing regulatory and macroeconomic shifts.
  • Identify high-potential opportunities by aligning products and business models with evolving industry and end-user needs.

Conclusion

This report provides a multidimensional orientation to the antiparasitic drugs market, empowering leaders to act on market complexity and transform innovation into competitive advantage. Actionable insights support growth, compliance, and stakeholder alignment across animal health value chains.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of ivermectin-based combination therapies for resistant helminthiasis in developing regions
5.2. Innovative topical formulations improving dermal penetration of antiparasitic agents for scabies treatment
5.3. Expansion of veterinary antiparasitic biologics targeting livestock parasite prevention to reduce chemical residues
5.4. Rising demand for single-dose oral macrocyclic lactone drugs in mass drug administration programs across Africa
5.5. Emergence of nanoformulation delivery systems enhancing antiparasitic drug efficacy and patient compliance
5.6. Increasing investments in digital diagnostic platforms for rapid detection of parasitic infections in remote areas
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antiparasitic Drugs Market, by Drug Class
8.1. Introduction
8.2. Amino-Acetonitrile
8.2.1. Monepantel
8.3. Benzimidazoles
8.3.1. Albendazole
8.3.2. Fenbendazole
8.3.3. Mebendazole
8.3.4. Oxibendazole
8.3.5. Thiabendazole
8.4. Macrocyclic Lactones
8.4.1. Abamectin
8.4.2. Doramectin
8.4.3. Eprinomectin
8.4.4. Ivermectin
8.5. Spiroindoles
8.5.1. Derquantel
9. Antiparasitic Drugs Market, by Veterinary
9.1. Introduction
9.2. Aquaculture
9.2.1. Fish
9.2.2. Shrimp
9.3. Companion Animals
9.3.1. Canine
9.3.2. Feline
9.4. Livestock
9.4.1. Cattle
9.4.2. Poultry
9.4.3. Swine
10. Americas Antiparasitic Drugs Market
10.1. Introduction
10.2. United States
10.3. Canada
10.4. Mexico
10.5. Brazil
10.6. Argentina
11. Europe, Middle East & Africa Antiparasitic Drugs Market
11.1. Introduction
11.2. United Kingdom
11.3. Germany
11.4. France
11.5. Russia
11.6. Italy
11.7. Spain
11.8. United Arab Emirates
11.9. Saudi Arabia
11.10. South Africa
11.11. Denmark
11.12. Netherlands
11.13. Qatar
11.14. Finland
11.15. Sweden
11.16. Nigeria
11.17. Egypt
11.18. Turkey
11.19. Israel
11.20. Norway
11.21. Poland
11.22. Switzerland
12. Asia-Pacific Antiparasitic Drugs Market
12.1. Introduction
12.2. China
12.3. India
12.4. Japan
12.5. Australia
12.6. South Korea
12.7. Indonesia
12.8. Thailand
12.9. Philippines
12.10. Malaysia
12.11. Singapore
12.12. Vietnam
12.13. Taiwan
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Analysis
13.3.1. Zoetis Inc.
13.3.2. Merck & Co., Inc.
13.3.3. Boehringer Ingelheim International GmbH
13.3.4. Elanco Animal Health Incorporated
13.3.5. Bayer AG
13.3.6. Ceva Santé Animale S.A.
13.3.7. Virbac S.A.
13.3.8. Dechra Pharmaceuticals PLC
13.3.9. Vetoquinol S.A.
13.3.10. Norbrook Laboratories Limited
14. ResearchAI
15. ResearchStatistics
16. ResearchContacts
17. ResearchArticles
18. Appendix
List of Figures
FIGURE 1. ANTIPARASITIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 10. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 12. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 18. ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 19. ANTIPARASITIC DRUGS MARKET: RESEARCHAI
FIGURE 20. ANTIPARASITIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 21. ANTIPARASITIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 22. ANTIPARASITIC DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIPARASITIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MONEPANTEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MONEPANTEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ALBENDAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ALBENDAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FENBENDAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FENBENDAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MEBENDAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MEBENDAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY OXIBENDAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY OXIBENDAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY THIABENDAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY THIABENDAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ABAMECTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ABAMECTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DORAMECTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DORAMECTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY EPRINOMECTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY EPRINOMECTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY IVERMECTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY IVERMECTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DERQUANTEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DERQUANTEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SHRIMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SHRIMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CANINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CANINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FELINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FELINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 118. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 119. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 120. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 121. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 122. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 123. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 124. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 125. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 126. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 127. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 128. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 129. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 130. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 131. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 132. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 133. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 134. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 227. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 228. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 229. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 230. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 231. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 232. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 233. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 234. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 235. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 236. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 237. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 238. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 239. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 242. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 243. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 244. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 245. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 246. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 247. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 248. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 249. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 250. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 251. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 252. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 253. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 254. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 255. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 256. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 257. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 260. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 261. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 262. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 281. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 282. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 283. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 284. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 285. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 286. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 287. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 288. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 289. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 290. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 291. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 292. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 293. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 294. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 295. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 296. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 297. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 298. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 299. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 300. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 301. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 302. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 303. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 304. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 305. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 306. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 307. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 308. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 309. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 310. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 311. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 312. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 313. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 314. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 315. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 316. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY MACROCYCLIC LACTONES, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY SPIROINDOLES, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY AMINO-ACETONITRILE, 2025-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antiparasitic Drugs market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Bayer AG
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Dechra Pharmaceuticals PLC
  • Vetoquinol S.A.
  • Norbrook Laboratories Limited

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.95 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antiparasitic Drugs Market Report 2025 - Product Image

Antiparasitic Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Veterinary Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Route Of Administration (Injectable, Oral, Topical), Animal Type, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Veterinary Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Route Of Administration (Injectable, Oral, Topical), Animal Type, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Indication (Bloodstream Infections, Gastrointestinal Infections, Respiratory Infections), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Indication (Bloodstream Infections, Gastrointestinal Infections, Respiratory Infections), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Veterinary Dermatology Market by Route of Administration, Product Type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition Type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal Type - Global Forecast to 2030 - Product Image

Veterinary Dermatology Market by Route of Administration, Product Type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition Type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal Type - Global Forecast to 2030

  • Report
  • 385 Pages
  • Global
From
Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From

About the Antiparasitic Agent Market

The Antiparasitic Agent market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs used to treat parasitic infections. Antiparasitic Agents are used to treat a variety of parasitic infections, including malaria, schistosomiasis, and leishmaniasis. These drugs are typically administered orally, intravenously, or topically, depending on the type of infection. Antiparasitic Agents are often used in combination with other drugs to ensure the most effective treatment. The Antiparasitic Agent market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, and Novartis. Other companies, such as Johnson & Johnson, Bayer, and AstraZeneca, also offer Antiparasitic Agents. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.